Faculty, Staff and Student Publications
Open-access journal articles from UTHealth GSBS faculty, staff and students.
Submissions from 2024
A Site-Wise Reliability Analysis of the ABCD Diffusion Fractional Anisotropy and Cortical Thickness: Impact of Scanner Platforms, Yezhi Pan, L Elliot Hong, Ashley Acheson, et al.
Hormonal Basis of Brain Fog in Cancer Treatment, Yuan Pan and Jian Hu
Nf1 Mutation Disrupts Activity-Dependent Oligodendroglial Plasticity and Motor Learning in Mice, Yuan Pan, Jared D Hysinger, Belgin Yalçın, et al.
Identification of A0 Minimum Ablative Margins for Colorectal Liver Metastases: Multicentre, Retrospective Study Using Deformable Ct Registration and Artificial Intelligence-Based Autosegmentation, Iwan Paolucci, Jessica Albuquerque Marques Silva, Yuan-Mao Lin, et al.
Genome-Wide Interaction Study of Dietary Intake of Fibre, Fruits, and Vegetables With Risk of Colorectal Cancer, Nikos Papadimitriou, Andre Kim, Eric S Kawaguchi, et al.
Incidence and Impact of Fungal Infections in Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease Prophylaxis and Haploidentical Hematopoietic Cell Transplantation: A Center for International Blood and Marrow Transplant Research Analysis, Genovefa A Papanicolaou, Min Chen, Naya He, et al.
Evolving Therapies, Neurocognitive Outcomes, and Functional Independence in Adult Survivors of Childhood Glioma, Chiara Papini, Sedigheh Mirzaei S, Mengqi Xing, et al.
Adding 6 Months of Androgen Deprivation Therapy to Postoperative Radiotherapy for Prostate Cancer: A Comparison of Short-Course Versus No Androgen Deprivation Therapy in the Radicals-HD Randomised Controlled Trial, Chris C Parker, Noel W Clarke, Adrian D Cook, et al.
Duration of Androgen Deprivation Therapy With Postoperative Radiotherapy for Prostate Cancer: A Comparison of Long-Course Versus Short-Course Androgen Deprivation Therapy in the Radicals-HD Randomised Trial, Chris C Parker, Howard Kynaston, Adrian D Cook, et al.
Assessing Radiology and Radiation Therapy Needs for Cancer Care in Low-and-Middle-Income Countries: Insight From a Global Survey of Departmental and Institutional Leaders, Stephanie A Parker, Joseph Weygand, Beata Gontova Bernat, et al.
Cancer Statistics in Korea: Incidence, Mortality, Survival, and Prevalence in 2021, Eun Hye Park, Kyu-Won Jung, Nam Ju Park, et al.
SMYD5 Methylation of rpL40 Links Ribosomal Output to Gastric Cancer, Juhyung Park, Jibo Wu, Krzysztof J Szkop, et al.
Comprehensive Analysis of Transcription Factor-Based Molecular Subtypes and Their Correlation to Clinical Outcomes in Small-Cell Lung Cancer, Sehhoon Park, Tae Hee Hong, Soohyun Hwang, et al.
Evaluation of Chronic Pancreatitis Prognosis Score in an American Cohort, Soo Kyung Park, Darwin L Conwell, Phil A Hart, et al.
Anti-Acetylated-Tau Immunotherapy Is Neuroprotective In Tauopathy and Brain Injury, Celeste Parra Bravo, Karen Krukowski, Sarah Barker, et al.
Multi-omics Analysis Reveals Immune Features Associated with Immunotherapy Benefit in Patients with Squamous Cell Lung Cancer from Phase III Lung-MAP S1400I Trial, Edwin Roger Parra, Jiexin Zhang, Dzifa Yawa Duose, et al.
Surgical Periodontal Management of Peripheral Ossifying Fibroma: A Series of Three Cases, Karo Parsegian, Roger M Arce, and Nikola Angelov
In-Patient Evolution of a High-Persister Escherichia coli Strain With Reduced In Vivo Antibiotic Susceptibility, Joshua B Parsons, Ashelyn E Sidders, Amanda Z Velez, et al.
AR (CAG)n Microsatellite and APEX1 c444T>G (pAsp148Glu) Polymorphisms As Independent Prognostic Biomarkers in Prostate Cancer: Insights From an Argentinian Cohort, Gaston Pascual, Agustina Sabater, Juan Bizzotto, et al.
Calibrating Tumor Growth and Invasion Parameters With Spectral Spatial Analysis of Cancer Biopsy Tissues, Stefano Pasetto, Michael Montejo, Mohammad U Zahid, et al.
Cancer Biomarkers: Emerging Trends and Clinical Implications for Personalized Treatment, Antonio Passaro, Maise Al Bakir, Emily G Hamilton, et al.
Outcomes of Patients With Multiple Myeloma and 1q Gain/Amplification Receiving Autologous Hematopoietic Stem Cell Transplant: The MD Anderson Cancer Center Experience, Oren Pasvolsky, Sassine Ghanem, Denái R Milton, et al.
Trends in Outcomes After Upfront Autologous Transplant for Multiple Myeloma Over Three Decades, Oren Pasvolsky, Curtis Marcoux, Jianliang Dai, et al.
Optimal Infused CD34+ Cell Dose in Multiple Myeloma Patients Undergoing Upfront Autologous Hematopoietic Stem Cell Transplantation, Oren Pasvolsky, Curtis Marcoux, Denái R Milton, et al.
Impact of Pretransplant Minimal Residual Disease in Patients With Multiple Myeloma and a Very Good Partial Response or Better Receiving Autologous Hematopoietic Stem Cell Transplantation, Oren Pasvolsky, Sarah Pasyar, Roland L Bassett, et al.